StockData
Twist Bioscience Corp logo

Twist Bioscience Corp (TWST) stock

TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$112.00+6.96 (+6.63%)

Close on Nov 17, 2026Market cap $7.02BP/E –Yield –

Twist Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Twist Bioscience's price to book ratio was 17.2× on Nov 11, 2026, against 4.1× a year earlier. Over the last 5 years it ranged from 0.9× to 27.2×, with a median of 4.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.2×+13.2
2025Dec 31, 20254.1×−1.7
2024Dec 31, 20245.8×+2.4
2023Dec 29, 20233.4×+1.7
2022Dec 30, 20221.7×−4.9
2021Dec 31, 20216.6×−12.3
2020Dec 31, 202018.9×+14.4
2019Dec 31, 20194.5×–

More Twist Bioscience figures

See a number that looks wrong?